*  Exposure Controls/Personal Protection  *
Respiratory Protection:ORGANIC VAPOR AIR-PURIFYING RESPIRATOR IS
    RECOMMENDED IF CONCENTRATIONS ARE ABOVE TLV/TWA, OR IF VAPORS ARE A
    NUISANCE.
Ventilation:PROVIDE SUFFICIENT MECHANICAL (GENERAL AND/OR LOCAL
    EXHAUST) VENTILATION TO MAINTAIN EXPOSURE BELOW TLV.
Other Protective Equipment:IMPERVIOUS APRON TO PREVENT PROLONGED SKIN
    CONTACT. PROVIDE AN EYE WASH STATIONS AND SAFETY SHOWER.
Work Hygienic Practices:WASH AFTER HANDLING AND BEFORE EATING,
    DRINKING, OR SMOKING. LAUNDER CONTAMINATED CLOTHING BEFORE REUSE.
Supplemental Safety and Health
PERSONAL PROTECTIVE EQUIPMENT SUGGESTIONS PERTAIN TO EMERGENCY
    ORGANIC VAPOR RESPIRATOR AND CLOTHING TO PREVENT PROLONGED SKIN
    CONTACT  IS SUFFICIENT UNDER CONDITIONS OF NORMAL USE.
*  Product Identification  *
Preparer's Name:P.A. ZOUBECK
*  Composition/Information on Ingredients  *
Ingred Name:SODIUM NITRITE (SARA III)
Fraction by Wt: 5%
Other REC Limits:NONE RECOMMENDED
Ingred Name:SODIUM MERCAPTOBENZOTHIAZOLE
Fraction by Wt: 5%
Other REC Limits:NONE RECOMMENDED
Ingred Name:SODIUM TETRABORATE
Fraction by Wt: 5%
Other REC Limits:NONE RECOMMENDED
Ingred Name:SODIUM NITRATE
Fraction by Wt: 5%
Other REC Limits:NONE RECOMMENDED
*  Hazards Identification  *
Routes of Entry: Inhalation:YES  Skin:YES  Ingestion:YES
Reports of Carcinogenicity:NTP:NO    IARC:NOOSHA:NO
Health Hazards Acute and Chronic:ACUTE: EYES: IRRITATION, BLURRED
    VISION, PAIN. SKIN: IRRITATION, DRY OR CRACKING SKIN. INHALATION:
    DIZZINESS, HEADACHE, UNCONSCIOUSNESS, ASPHYXIATION. INGESTION:
    NAUSEA, CRAMPS, VOMITING, KIDNEY DAMAG E, DEATH. CHRONIC:
    EXPERIMENTAL STUDIESON ANIMALS HAVE SHOWN REPRODUCTIVE DEFECTS FROM
    EXPOSURE TO SODIUM NITRITE.
Explanation of Carcinogenicity:THIS PRODUCT IS NOT CONSIDERED A
    CARCINOGEN BY NTP, IARC, OSHA.
Effects of Overexposure:EYES: IRRITATION, REDNESS, TEARING, BLURRED
    VISION, PAIN. SKIN: IRRITATION, REDNESS, DRY OR CRACKING SKIN.
    INHALATION: DIZZINESS, HEADACHE, UNCONSCIOUSNESS, ASPHYXIATION.
    INGESTION: NAUSEA, CRAMPS, VO MITING, KIDNEY DAMAGE, DEATH.
Medical Cond Aggravated by Exposure:PREGNANT WOMEN MAY BE SENSITIVE TO
    SODIUM NITRITE CONTAINED IN THIS PRODUCT.
*  First Aid Measures  *
First Aid:EYES: FLUSH WITH LARGE AMOUNTS OF WATER. GET MEDICAL
    ATTENTION IMMEDIATELY. SKIN: REMOVE CONTAMINATED CLOTHING. WASH
    AREA WITH SOAP AND WATER. IF IRRITATION PERSISTS, GET MEDICAL
    ATTENTION. INHALATION : MOVE TO FRESH AIR. RESTORE NORMAL
    BREATHING. GET MEDICAL ATTENTION. INGESTION: INDUCE VOMITING AND
    GIVE WATER TO CONSCIOUS VICTIM. GET MEDICAL ATTENTION.
*  Fire Fighting Measures  *
Flash Point:NONE
Extinguishing Media:NONE SPECIFIED BY MANUFACTURER.
Fire Fighting Procedures:WATER SPRAY MAY BE USED TO COOL FIRE EXPOSED
    CONTAINERS PREVENTING PRESSURE BUILD-UP AND EXPLOSION.
Unusual Fire/Explosion Hazard:MAY EVOLVE OXIDES OF NITROGEN UNDER FIRE
    CONDITIONS.
*  Accidental Release Measures  *
Spill Release Procedures:DIKE SPILL AND COLLECT PRODUCT WITH INERT
    ABSORBENT AND PLACE RECLAIMED LIQUID AND ABSORBENT INTO RECOVERY
    DRUMS FOR DISPOSAL.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
*Handling and Storage  *
Handling and Storage Precautions:NONE SPECIFIED BY MANUFACTURER.
Other Precautions:WHEN DISPOSING OF THIS LIQUID, AS A NON-HAZARDOUS
    WASTE, IT SHOULD BE SOLIDIFIED WITH STABILIZING AGENTS SUCH AS SAND
    OR FLY ASH.
*  Physical/Chemical Properties  *
HCC:B3
Vapor Density:9.7
Appearance and Odor:REDISH LIQUID. NO ODOR.
*  Stability and Reactivity Data  *
Stability Indicator/Materials to Avoid:YES
STRONG ACIDS SUCH AS SULFURIC ACID, PHOSPHORIC ACID, NITRIC ACID.
Stability Condition to Avoid:HIGH TEMPERATURES.
Hazardous Decomposition Products:CARBON MONOXIDE, CARBON DIOXIDE,
    OXIDES OF NITROGEN.
Conditions to Avoid Polymerization:CANNOT OCCUR.
*  Disposal Considerations  *
Waste Disposal Methods:DISPOSE OF WASTE IN ACCORDANCE WITH LOCAL, STATE
    AND FEDERAL REGULATIONS. THIS PRODUCT DOES NOT MEET THE CRITERIA AS
    THE CHARACTERIST ICS OF SUBPART C NOR IS IT LISTED UNDERSUBPART D.
